US · Healthcare

Vaxil Bio Ltd (VXLLF)

Biotechnology

Vaxil Bio Ltd (VXLLF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VXLLF

P/E ratio

25.00

Vaxil Bio Ltd (VXLLF) — FAQ

What is VXLLF's P/E ratio?

The price-to-earnings (P/E) ratio for Vaxil Bio Ltd (VXLLF) is 25.00 (data as of 2026-05-23).

Does Vaxil Bio Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Vaxil Bio Ltd (VXLLF). Check the MyAverix Finance app for the latest dividend data.

What sector is Vaxil Bio Ltd in?

Vaxil Bio Ltd (VXLLF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is VXLLF listed on?

VXLLF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)